FindTrial
Sign In

Open-labeled prospective clinical trial of Axona(R) in the treatment of mild to moderate Alzheimer's disease.

Open-labeled prospective clinical trial of Axona(R) in the treatment of mild to moderate Alzheimer's disease. - Clinical trial of Axona(R) for Alzheimer's disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000013591
Enrollment
30
Registered
2014-05-01
Start date
2014-03-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild to moderate Alzheimer&#39

Interventions

Patients taking Axona(R).

Sponsors

Dept. of Psychiatry, Juntendo University Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed as mild to moderate Alzheimer's disease (MMSE10~26).

Exclusion criteria

Exclusion criteria: 1) Patients already showing severe diarrhea. 2) Patients with severe state of diabetes and ketoasidosis.

Design outcomes

Primary

MeasureTime frame
Intolerance scale, blood test (incl. ketone body and HbA1c), cognitive battery test (ADAS-Jcog, MMSE)—

Countries

Japan

Contacts

Public ContactTohru Ohnuma

Juntendo University Faculty of Medicine Department of Psychiatry

otoru@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026